Literature DB >> 9887235

Intraperitoneal pressures and clinical parameters of total paracentesis for palliation of symptomatic ascites in ovarian cancer.

W H Gotlieb1, B Feldman, O Feldman-Moran, N Zmira, D Kreizer, Y Segal, E Elran, G Ben-Baruch.   

Abstract

OBJECTIVE: The present study was designed to prospectively evaluate the intraperitoneal pressure, as well as clinical and hemodynamic effects of total paracentesis, as palliation of symptomatic ascites in ovarian cancer patients.
METHODS: Prospective study of 35 sequential total paracenteses was performed using a Veres cannula on patients with advanced recurrent ovarian cancer with symptomatic tense ascites. Relevant clinical symptoms and patient well-being were evaluated. Vital signs, abdominal parameters, and hydrostatic intraperitoneal pressure were recorded before, during, and after the procedure.
RESULTS: Intraperitoneal pressure dropped from 30 +/- 7 cmH2O before paracentesis to 13 +/- 6 cmH2O after the procedure (P < 0.0001). Marked symptomatic improvement was observed in all patients (89% complete relief, 11% partial relief), while all the patients tolerated the procedure well without any complications. The mean volume of ascitic fluid removed was 4800 ml. Mean respiratory rate and mean heart rate were both significantly decreased following the procedure (29.3 to 21.4 respirations per min and 101.5 to 93.6 beats per min, respectively). Mean systolic blood pressure mildly decreased (6.6 mmHg), while the mean diastolic blood pressure did not significantly change. None of the patients presented signs or symptoms of hypovolemia during or after the total paracentesis.
CONCLUSIONS: Measurement of intraperitoneal pressures during total paracentesis for tense ascites in ovarian cancer patients indicated that the severity of symptoms correlated with the intraperitoneal pressure prior to paracentesis, but not with the volume of ascites. Intraperitoneal pressures measured following total paracentesis in patients with ovarian cancer were similar to the baseline intraperitoneal pressure measured in patients undergoing peritoneal dialysis. Copyright 1998 Academic Press.

Entities:  

Mesh:

Year:  1998        PMID: 9887235     DOI: 10.1006/gyno.1998.5215

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  14 in total

1.  Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations.

Authors:  Michael L Cheatham; Manu L N G Malbrain; Andrew Kirkpatrick; Michael Sugrue; Michael Parr; Jan De Waele; Zsolt Balogh; Ari Leppäniemi; Claudia Olvera; Rao Ivatury; Scott D'Amours; Julia Wendon; Ken Hillman; Alexander Wilmer
Journal:  Intensive Care Med       Date:  2007-03-22       Impact factor: 17.440

2.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

3.  Safety, cost-effectiveness and feasibility of daycase paracentesis in the management of malignant ascites with a focus on ovarian cancer.

Authors:  V Harding; E Fenu; H Medani; R Shaboodien; S Ngan; H K Li; R Burt; N Diamantis; M Tuthill; S Blagden; H Gabra; C E Urch; S Moser; R Agarwal
Journal:  Br J Cancer       Date:  2012-08-09       Impact factor: 7.640

Review 4.  Diverse mechanisms for activation of Wnt signalling in the ovarian tumour microenvironment.

Authors:  Maria V Barbolina; Rebecca J Burkhalter; M Sharon Stack
Journal:  Biochem J       Date:  2011-07-01       Impact factor: 3.857

Review 5.  Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Clin Pharmacol       Date:  2013-10-03

6.  Large-volume paracentesis with indwelling peritoneal catheter and albumin infusion: a community hospital study.

Authors:  Daniel K Martin; Saqib Walayat; Ren Jinma; Zohair Ahmed; Karthik Ragunathan; Sonu Dhillon
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-10-26

7.  Emerging treatment options for management of malignant ascites in patients with ovarian cancer.

Authors:  Ramez N Eskander; Krishnansu S Tewari
Journal:  Int J Womens Health       Date:  2012-08-03

8.  Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.

Authors:  Bruce Crawford; Elizabeth Piault; Walter Gotlieb; Florence Joulain
Journal:  Patient Relat Outcome Meas       Date:  2012-06-21

Review 9.  Management of ascites due to gastrointestinal malignancy.

Authors:  Muhammad W Saif; Imran A P Siddiqui; Muhammad A Sohail
Journal:  Ann Saudi Med       Date:  2009 Sep-Oct       Impact factor: 1.526

10.  Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery*: A Prospective Substudy of a Randomized Controlled Trial.

Authors:  Oliver Hunsicker; Christina Fotopoulou; Klaus Pietzner; Mandy Koch; Alexander Krannich; Jalid Sehouli; Claudia Spies; Aarne Feldheiser
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.